PubMed ID: 29103793 Author(s): Sadda SR, Guymer R, Holz FG, Schmitz-Valckenberg S, Curcio CA, Bird AC, Blodi BA, Bottoni F, Chakravarthy U, Chew EY, Csaky K, Danis RP, Fleckenstein M, Freund KB, Grunwald J, Hoyng …
WRC
Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti-Vascular Endothelial Growth Factor Medications: Secondary Outcomes From the SCORE2 Randomized Clinical Trial.
PubMed ID: 29476687 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Altaweel M, Berinstein DM; SCORE2 Investigator Group. Comparison of monthly vs treat-and-extend regimens for individuals with macular edema who respond well …
Propranolol for Proliferative Diabetic Retinopathy.
PubMed ID: 29304264 Author(s): Hendrick AM, Lavine JA, Domalpally A</strong>, Kulkarni AD, Ip MS. Propranolol for proliferative diabetic retinopathy. Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):35-40. doi: 10.3928/23258160-20171215-05. PMID 29304264 Journal: Ophthalmic Surgery, Lasers …
SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.
PubMed ID: 29074161 Author(s): Scott IU, Figueroa MJ, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE2 Investigator Group. SCORE2 report 5: vision-related function in patients with macular edema secondary to central retinal or hemiretinal …
Change in Diabetic Retinopathy Through 2 Years: Secondary Analysis of a Randomized Clinical Trial Comparing Aflibercept, Bevacizumab, and Ranibizumab.
PubMed ID: 28448655 Author(s): Bressler SB, Liu D, Glassman AR, Blodi BA, Castellarin AA, Jampol LM, Kaufman PL, Melia M, Singh H, Wells JA; Diabetic Retinopathy Clinical Research Network. Change in diabetic retinopathy through 2 …
Baseline Factors Associated With 6-Month Visual Acuity and Retinal Thickness Outcomes in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Study Report 4.
PubMed ID: 28492860 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, King J, Antoszyk AN, Peters MA, Tolentino M; SCORE2 Investigator Group. Baseline factors associated with 6-month visual acuity and retinal thickness …
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial.
PubMed ID: 28492910 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Awh CC, Kunimoto DY, Marcus DM, Wroblewski JJ, King J; SCORE2 Investigator Group. Effect of bevacizumab vs aflibercept on visual acuity …
SCORE2 Report 2: Study Design and Baseline Characteristics.
PubMed ID: 27863843 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M, Dugel PU; SCORE2 Investigator Group. SCORE2 report 2: study design and baseline characteristics. Ophthalmology. 2017 Feb;124(2):245-256. doi: 10.1016/j.ophtha.2016.09.038. Epub …
Evaluation of Geographic Atrophy from Color Photographs and Fundus Autofluorescence Images: Age-Related Eye Disease Study 2 Report Number 11.
PubMed ID: 27448832 Author(s): Domalpally A, Danis R, Agrón E, Blodi B, Clemons T, Chew E; Age-Related Eye Disease Study 2 Research Group. Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related …